Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway
A study finds Rab14 functions as an oncogene in gastric cancer cells by targeting through AKT pathway. This is a novel evidence... Read More
Bursectomy Not Recommended as Standard Treatment for cT3/T4 Gastric Cancer
Bursectomy can be safely performed without increasing the risk of morbidity or mortality among patients with cT3 or cT4 gastric cancer, though... Read More
‘Collateral’ lethality may offer new therapeutic approach for cancers of the pancreas, stomach and colon
Heard of collateral lethality? It’s a therapeutic strategy that uses gene deletions with no direct role in the tumor progression. A recent... Read More
miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression
New Plos Onestudy shows miR-1296-5p may be a tumor suppressor of the miRNA molecule in gastric cancer as well as a clinical... Read More
Faulty DNA error correction genes set stage for familial gastric cancer
Published in the Gastroenterology Journal, UC Davis researchers have identified genetic variations that contribute to familial gastric cancer. Inherited mutations – which... Read More
Scientists find new check for recurrence risk of gastric cancer
Researchers have developed a technique to identify patients who are more likely to suffer a recurrence of gastric cancer based on the... Read More
Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway
While the development of chemoresistance and metastasis are the leading causes of death for gastric cancer patients, the molecular mechanisms involved remain... Read More
Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer
New AACR research shows circulating microRNAs in serum may serve as promising diagnostic biomarkers for patients with gastric cancer.
Ramucirumab Beneficial in Advanced Gastric/GEJ Cancers Regardless of Age
Regardless of age, patients with advanced gastric or gastroesophageal juncture (GEJ) cancer saw a survival benefit when treated with the monoclonal antibody... Read More
Surgical Palliation Enables Solid Food Intake in Advanced Incurable Gastric Cancer
A first of its kind study presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco shows surgical palliation in patients treated... Read More
